CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma
2018 · Journal of Experimental & Clinical Cancer Research · 79 citations
https://doi.org/10.1186/s13046-018-0699-1
Y
Yongjian Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
1.2K
Citations
19
h-index
28
i10-index
Yongjian Zhang is an academic researcher from Shandong University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & MicroRNA in disease regulation & Ovarian cancer diagnosis and treatment. The author has an h-index of 19, co-authored 77 publications.
ORCID: 0000-0002-4975-452XPapers by this author
worksMetabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2
2019 · Molecular Carcinogenesis · 52 citations
https://doi.org/10.1002/mc.22967
Resveratrol synergistically augments anti-tumor effect of 5-FU <i>in vitro</i> and <i>in vivo</i> by increasing S-phase arrest and tumor apoptosis
2015 · Experimental Biology and Medicine · 49 citations
https://doi.org/10.1177/1535370215573396
Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR‐362‐5p/Nf‐κB axis
2018 · Journal of Cellular Physiology · 47 citations
https://doi.org/10.1002/jcp.26446
CPEB3-mediated MTDH mRNA translational suppression restrains hepatocellular carcinoma progression
2020 · Cell Death and Disease · 43 citations
https://doi.org/10.1038/s41419-020-02984-y
Analysis of the carbon emission driving factors and prediction of a carbon peak scenario——A case study of Xi'an city
2022 · Heliyon · 31 citations
https://doi.org/10.1016/j.heliyon.2022.e11753
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat